Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 





Register here to be notified of future BCT Company articles
View full BCT profile View Profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015
Newswire
August 28 2014

Related Articles

wood chip pile
July 03 2017
Acquisitions over the past year had driven the improvement and will give sales a further kicker in the current year.
bluechiip-andrew-mclelland-presenting-Syd-Mar-2017.png
March 17 2017
Andrew McLellan discussed with investors wiresless tracking technology.
coins as a bar chart denoting financial growth
August 01 2017
Strong organic growth complemented Tavistock’s buy and build strategy

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use